A Look into Biopreservation Industry……Deep Analysis…..
The global biopreservation
market size is expected to reach USD 8.93 billion by 2022, according to
a new report by Grand View Research, Inc., exhibiting a 17.3% CAGR during the forecast period. Rising demand for advanced
preservation methods and constantly increasing healthcare spending is
anticipated to fuel growth potential in future. Hospitals, pharmaceutical
companies, and biotechnology firms are increasingly adopting systems for
in-house storage of samples and this is anticipated to provide a significant
boost to the market. Surging R&D investments by major companies and
research communities striving to improve product development capabilities is
also presenting the market with immense potential.
Biopharmaceutical innovators are at the
forefront of the human response to the coronavirus pandemic. A significant
number of major biotech firms are in the midst of a race to investigate the
Sars-Cov-2 genome and prepare a viable vaccine for the same. As compared to the
speed of response to SARS/MERs etc, the biotech entities are investigating
SARs-Cov-2 at an unprecedented rate and a considerable amount of funds are
being put into the R&D. With multiple candidates in trial, the public and
private sectors are anticipated to work in unison for the foreseeable period,
until a vaccine is developed for Covid-19. The report will account for Covid19
as a key market contributor.
Technological advancements such as
advent of virtual bio-banks, which is predicted to witness a significant
upsurge in the application, is also resulting in market progression. In
addition, increasing preference for maintaining repositories for biological
specimens, for application in organ transplantation and regenerative medicine,
has benefited the market. Presence of government initiatives such as
International Society of Biological and Environmental Repositories to enhance
bio-banking and preservation standards and practices is also broadening the
scope for growth over the coming years.
The market is
highly competitive, characterized by deployment of sustainability strategies by
prominent players such as BioLife Solutions Inc.; BioCision; Biomatrica; and
Chart MVE Biomedical. These companies have been focused on strategies such as
geographical expansion, new product development initiatives, and mergers and
acquisitions to gain competitive advantage. The market is highly competitive,
characterized by deployment of sustainability strategies by prominent players
such as BioLife Solutions Inc.; BioCision; Biomatrica; and Chart MVE
Biomedical. These companies have been focused on strategies such as
geographical expansion, new product development initiatives, and mergers and
acquisitions to gain competitive advantage.
To Request Sample Copy of this report, click the link:
The global biopreservation market
size was estimated at USD 3.53 billion in 2016 and is anticipated to expand at
a CAGR of 17.3% during the forecast period. Growing healthcare expenditure is a
significant growth contributing factor for this market. This upsurge in
healthcare spending is a consequence of rapid economic development across the
globe.
Further key findings from the report suggest:
·
In 2014, equipment captured the
dominant share by product owing to growing demand from bio-banks. High
preservation costs of biological specimens has also benefited this segment
·
The media segment, on the other
hand, is predicted to witness exponential CAGR during the coming years as a
result of wide adoption in regenerative medicine
·
In 2014, bio-banking captured a
substantial share in terms of application owing to growing number of tissue and
organ transplantations and high awareness levels with respect to bio-banking
·
Regenerative medicine, on the
other hand, is anticipated to register the highest CAGR owing to major
investments by public and private healthcare organizations in research focused
on restorative therapy
·
By cell provider, tumor cells
captured the largest share in terms of volume in 2014, as a consequence of
extensive application in R&D and treatment of cancers with high prevalence
·
In 2014, North America
accounted for the largest share in the biopreservation market, which can be
attributed to existing government regulations supporting extensive usage of
biological samples in regenerative medicine
·
Asia Pacific is anticipated to
observe exponential growth throughout the forecast period owing to unmet
clinical needs in the region, coupled with continued infrastructure upgradation
·
Key market players are involved
in deploying extensive strategies such as new product development, mergers, and
acquisitions to gain competitive edge over other players.
Increase
in healthcare expenditure further is predicted to improve access to quality
healthcare and advanced products, which include biopreservation facilities,
thereby broadening growth prospects. In addition, hospitals, gene banks, and
bio-banks, which are significant end-users for this market, are encouraging
major players to develop technologically advanced biopreservation products to
enhance patient outcomes.
Presence
of government healthcare initiatives that provide funds, grants, and contracts
for research have resulted in providing expedited growth to R&D activities
deployed by various companies. This has, in turn, resulted in widening the
scope for adoption of advanced bio-preservation services, which is anticipated
to fuel penetration rate throughout the forecast period.
Technological
advancements in biopreservation processes are also major growth contributing
factors to the market. Advancements include change in formulation of
hypothermic storage solutions, next-generation cryopreservation solutions, and
design and integration with nanoscale technologies. These technological
upgradations have led to long-term preservation and banking of complex organs
and tissues of high importance in regenerative medicine and organ
transplantation.
Increasing
R&D investments by companies and research communities to enhance their
capabilities and render efficient products and services is predicted to further
expand growth prospects. For instance, the establishment of Cooperative Human
Tissue Network (CHTN), which addressed the operational dimension of
bio-banking, exemplifies consistent efforts by the research community.
Browse Press
Release of this report:
Grand View Research has segmented the
global biopreservation market on the basis of product, application, cell
provider, and region:
Biopreservation Product Outlook (Revenue, USD Million,
2012 - 2022)
·
Equipment
o Freezers
o Refrigerators
o Consumables
o Vials
o Straws
o Microtiter Plates
o Bags
o Liquid Nitrogen
·
Media
o Pre-formulated
o Home-brew
·
Laboratory Information
Management System (LIMS)
Biopreservation Application Outlook (Revenue, USD
Million, 2012 - 2022)
·
Regenerative Medicine
o Cell Therapy
o Gene Therapy
o Others
·
Bio-banking
o Human Eggs
o Human Sperm
o Veterinary IVF
·
Drug Discovery
Biopreservation Cell Provider Outlook (Volume, 000’
Units, 2012 - 2022)
·
CD34+
·
CD19+
·
MSC
·
iPSC
·
hESC
·
Tumor Cells
·
Others
About Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.

Comments
Post a Comment